Alexandra H. Filipovich
#139,164
Most Influential Person Now
Alexandra H. Filipovich's AcademicInfluence.com Rankings
Alexandra H. Filipovichphilosophy Degrees
Philosophy
#7179
World Rank
#10352
Historical Rank
Logic
#4248
World Rank
#5518
Historical Rank
Alexandra H. Filipovichbiology Degrees
Biology
#9751
World Rank
#12994
Historical Rank
Immunology
#590
World Rank
#610
Historical Rank
Download Badge
Philosophy Biology
Alexandra H. Filipovich's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Immunology Stanford University
Why Is Alexandra H. Filipovich Influential?
(Suggest an Edit or Addition)Alexandra H. Filipovich's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis (2007) (3920)
- National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. (2005) (1947)
- Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans (1993) (1217)
- How I treat hemophagocytic lymphohistiocytosis. (2011) (872)
- Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. (1993) (837)
- Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. (2001) (776)
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. (2002) (753)
- Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome (2002) (719)
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. (2004) (701)
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. (2001) (652)
- Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy (2015) (493)
- HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. (1997) (477)
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. (2011) (475)
- ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. (1994) (474)
- Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. (2004) (397)
- Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. (2006) (394)
- Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. (2017) (365)
- Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. (1990) (362)
- Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. (2004) (360)
- Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. (2011) (338)
- Hemophagocytic lymphohistiocytosis (HLH) and related disorders. (2009) (332)
- Transplantation outcomes for severe combined immunodeficiency, 2000-2009. (2014) (326)
- New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (2000) (314)
- A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. (2014) (312)
- Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. (2006) (299)
- The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. (2007) (293)
- Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. (2001) (274)
- RISK FACTORS FOR ACUTE GRAFT‐VERSUS‐HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE MARROW TRANSPLANTATION (1991) (269)
- Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. (1995) (264)
- Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. (2003) (257)
- Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. (2001) (245)
- Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab (2013) (240)
- Histiocytic disorders: recent insights into pathophysiology and practical guidelines. (2010) (237)
- Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. (2002) (235)
- Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. (2010) (230)
- XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. (2010) (229)
- Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome (2004) (226)
- Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis (2005) (214)
- Primary immunodeficiencies: genetic risk factors for lymphoma. (1992) (210)
- Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis (2008) (209)
- Hemophagocytosis causes a consumptive anemia of inflammation (2011) (194)
- Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. (2013) (188)
- Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis (2004) (185)
- Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. (1988) (181)
- Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. (2003) (180)
- Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. (2009) (172)
- EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (1984) (169)
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. (2008) (165)
- Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. (2007) (164)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. (2006) (160)
- Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. (2002) (157)
- Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. (1990) (156)
- Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. (2012) (156)
- Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. (2009) (155)
- Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. (2006) (155)
- X-linked lymphoproliferative syndromes: brothers or distant cousins? (2010) (154)
- Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis (2014) (149)
- PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION (1982) (142)
- Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. (1995) (137)
- Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. (2014) (136)
- Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. (2008) (136)
- Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. (1985) (133)
- Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations (2007) (132)
- Hemophagocytic lymphohistiocytosis and related disorders (2006) (130)
- Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children – a Eurocord analysis (2001) (130)
- Defective Natural Killer Cell Function in Patients with Hemophagocytic Lymphohistiocytosis and in First Degree Relatives (1998) (129)
- A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. (2000) (128)
- Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993. (2008) (127)
- Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. (2013) (126)
- Virus‐Associated Histiocytic Proliferations in Children: Frequent Association with Epstein‐Barr Virus and Congenital or Acquired Immunodeficiencies (1988) (122)
- transplants in children with acute leukemia Comparison of outcomes of unrelated bone marrow and umbilical cord blood (2011) (118)
- Hypoxia Regulates Expression and Activity of Kv1.3 Channels in T Lymphocytes: A Possible Role in T Cell Proliferation1 (2003) (115)
- Interplay of Adaptive Th2 Immunity with Eotaxin-3/C-C Chemokine Receptor 3 in Eosinophilic Esophagitis (2007) (112)
- The accelerated phase of Chediak‐Higashi syndrome. An expression of the virus‐associated hemophagocytic syndrome? (1985) (111)
- Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. (2014) (108)
- Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. (2005) (105)
- Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. (2008) (105)
- The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901 (2013) (105)
- Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. (1997) (104)
- Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (2008) (104)
- Relationship of immunodeficiency to lymphoid malignancy (1988) (103)
- Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. (2008) (101)
- Lymphoproliferative disorders and other tumors complicating immunodeficiencies. (1994) (99)
- Diagnosis and manifestations of chronic graft-versus-host disease. (2008) (98)
- Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. (2012) (96)
- Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. (1992) (95)
- Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. (2011) (95)
- The expanding spectrum of hemophagocytic lymphohistiocytosis (2011) (94)
- Immunodeficiency in humans as a risk factor in the development of malignancy. (1980) (94)
- Long‐term outcomes of 176 patients with X‐linked hyper‐IgM syndrome treated with or without hematopoietic cell transplantation (2017) (93)
- Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. (1991) (91)
- Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. (2014) (91)
- Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. (1992) (89)
- Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. (2011) (87)
- Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. (1994) (84)
- Munc18b/STXBP2 is required for platelet secretion. (2012) (82)
- The Immunodeficiency Cancer Registry. A research resource. (1987) (81)
- Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow. (1987) (76)
- Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study. (1982) (74)
- Biphenotypic leukemia: immunologic and morphologic evidence for a common lymphoid-myeloid progenitor in humans. (1983) (74)
- Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. (1990) (73)
- Response to thalidomide therapy in refractory chronic graft-versus-host disease (2000) (73)
- Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. (1996) (72)
- Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. (2008) (72)
- Pathogenesis of Hemophagocytic Lymphohistiocytosis. (2015) (70)
- Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. (1994) (68)
- Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience (2007) (67)
- Hypoxia modulates early events in T cell receptor‐mediated activation in human T lymphocytes via Kv1.3 channels (2005) (66)
- Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome (2012) (65)
- An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. (2013) (65)
- Reduced‐intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward (2011) (65)
- Hematopoietic cell transplantation for correction of primary immunodeficiencies (2008) (64)
- Primary Immune Deficiency Treatment Consortium (PIDTC) report. (2014) (64)
- Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen. (2015) (61)
- Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. (2005) (61)
- A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency (2009) (60)
- T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. (1999) (59)
- Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT. (2016) (59)
- Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. (2009) (58)
- Altered Dynamics of Kv1.3 Channel Compartmentalization in the Immunological Synapse in Systemic Lupus Erythematosus1 (2007) (57)
- 'Pseudolymphoma'. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. (1981) (55)
- Prevention and treatment of acute graft-versus-host disease. (1984) (55)
- Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. (2010) (52)
- Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (2006) (52)
- Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases. (2015) (51)
- Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. (1994) (51)
- STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America (2010) (50)
- High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study. (2006) (49)
- Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning (2015) (48)
- Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1. (2014) (46)
- Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome (2017) (46)
- Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis (2013) (46)
- Signalling during hypoxia in human T lymphocytes – critical role of the src protein tyrosine kinase p56Lck in the O2 sensitivity of Kv1.3 channels (2006) (45)
- Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF. (1995) (45)
- Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study. (2010) (45)
- Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation. (2006) (43)
- Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. (1988) (43)
- Graft-versus-host-disease-like histopathological findings in pre-bone-marrow transplantation biopsies of patients with severe T cell deficiency. (1985) (42)
- Fulminant liver failure induced by adenovirus after bone marrow transplantation. (1985) (42)
- Successful early intervention for hyperacute transplant‐associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation (2012) (41)
- Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. (2005) (41)
- Bortezomib for refractory autoimmunity in pediatrics. (2014) (41)
- Suppressor cell number and function in alopecia areata. (1984) (41)
- T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease. (1990) (39)
- ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival (1997) (39)
- PAX1 is essential for development and function of the human thymus (2020) (39)
- Familial alopecia areata. HLA antigens and autoantibody formation in an American family. (1984) (38)
- Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. (2011) (37)
- Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. (1998) (37)
- Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation. (2016) (37)
- Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. (2006) (37)
- Impaired immune function in children with Fanconi anaemia (2011) (36)
- Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus (2008) (35)
- Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. (2011) (34)
- Hodgkin's disease in pediatric patients with naturally occurring immunodeficiency. (1987) (33)
- Hemophagocytic Lymphohistiocytosis, Familial (2013) (32)
- Epstein-Barr Virus–Induced Hemophagocytic Lymphohistiocytosis and X-Linked Lymphoproliferative Disease: A Mimicker of Sepsis in the Pediatric Intensive Care Unit (2007) (31)
- A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. (2016) (30)
- A hereditary immunodeficiency characterized by CD8 T lymphocyte deficiency and impaired lymphocyte activation (1992) (30)
- Life‐threatening hemophagocytic syndromes: Current outcomes with hematopoietic stem cell transplantation (2005) (29)
- Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations. (2015) (29)
- Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL). (1994) (28)
- Emergence and Compartmentalization of Fatal Multi-Drug-Resistant Cytomegalovirus Infection in a Patient With Autosomal-Recessive Severe Combined Immune Deficiency (2004) (28)
- Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. (1986) (27)
- Ex vivo T cell depletion with immunotoxins in allogeneic bone marrow transplantation: The pilot clinical study for prevention of graft-versus-host disease (1985) (27)
- Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations (2014) (26)
- Real-Time Detection of CTL Function Reveals Distinct Patterns of Caspase Activation Mediated by Fas versus Granzyme B (2014) (26)
- The 253‐kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3 (2014) (26)
- Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi Anemia (2003) (25)
- Clinical Flow Cytometric Screening of SAP and XIAP Expression Accurately Identifies Patients with SH2D1A and XIAP/BIRC4 Mutations. (2014) (25)
- Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients. (2016) (25)
- Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene (2014) (25)
- Serum 5'nucleotidase and alkaline phosphatase--highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients. (1989) (25)
- Fatal arteritis as a complication of Wiskott-Aldrich syndrome. (1979) (24)
- Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor. (1986) (24)
- Graft‐versus‐host disease prophylaxis with anti‐T‐cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone‐marrow transplantation (1985) (23)
- Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex. (2012) (23)
- Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. (1993) (22)
- Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients. (1992) (22)
- Mismatched bone marrow transplantation for Omenn syndrome: a variant of severe combined immunodeficiency. (1995) (21)
- Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis. (2013) (21)
- Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment (2016) (20)
- Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated? (2009) (20)
- Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease. (2015) (20)
- Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease. (1985) (19)
- Outcomes Following Hematopoietic Cell Transplantation for Wiskott Aldrich Syndrome (2011) (18)
- B-cell lymphoproliferative disorders in children after bone marrow transplantation: radiologic manifestations. (1987) (18)
- Hemophagocytic lymphohistiocytosis: a lethal disorder of immune regulation. (1997) (18)
- STEM CELL TRANSPLANTATION FROM UNRELATED DONORS FOR CORRECTION OF PRIMARY IMMUNODEFICIENCIES (1996) (18)
- Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation (1991) (17)
- Successful allogeneic cryopreserved marrow transplantation (1989) (17)
- Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. (2001) (16)
- Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis. (2013) (15)
- Epidermodysplasia verruciformis in a Setting of Common Variable Immunodeficiency (1984) (15)
- Bone marrow transplantation across major histocompatibility barriers in mice. IV. Graft-versus-host disease in TLI-conditioned mice. (1982) (15)
- Bone marrow transplantation for acute lymphocytic leukemia. (1985) (13)
- Cutaneous infection with Metarhizium anisopliae in a patient with hypohidrotic ectodermal dysplasia and immune deficiency. (2008) (13)
- Activated phosphoinositide 3-kinase δ syndrome in a patient with a former diagnosis of common variable immune deficiency, bronchiectasis, and lymphoproliferative disease. (2015) (13)
- Lymphoma after thymus transplantation. (1980) (12)
- The successful use of alemtuzumab for treatment of steroid‐refractory acute graft‐versus‐host disease in pediatric patients (2014) (11)
- Enteral metronidazole for the prevention of graft-versus-host disease in pediatric marrow transplant recipients: results of a pilot study (2005) (11)
- The correlation between inducer/suppressor ratios, generation of concanavalin A-activated suppressor cells, and mitogen-stimulated proliferation of peripheral blood lymphocytes in patients with alopecia areata and normal controls. (1982) (10)
- Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow. (1985) (10)
- Bone marrow transplantation from unrelated donors for congenital immunodeficiencies. (1993) (9)
- Identification of transfused blood cells in children with severe combined immunodeficiency syndrome by analysis of multiple cell lineages using restriction fragment length polymorphisms. (1990) (9)
- Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot study (2004) (9)
- Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity. (2012) (9)
- Altered Dynamics of Kv 1 . 3 Channel Compartmentalization in the Immunological Synapse in Systemic Lupus Erythematosus 1 (2007) (8)
- Familial hemophagocytic lymphohistiocytosis and X‐linked lymphoproliferative disease (2011) (8)
- Immunoreconstitution by Bone Marrow Transplantation Decreases Lymphoproliferative Malignancies in Wiskott-Aldrich and Severe Combined Immune Deficiency Syndromes (1984) (8)
- Complications of transplant for nonmalignant disorders: autoimmune cytopenias, opportunistic infections, and PTLD. (2012) (7)
- B-lymphocyte function in immunodeficiency disease. (1983) (7)
- Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation. (1991) (7)
- MicroRNA activation signature in patients with hemophagocytic lymphohistiocytosis and reversibility with disease-specific therapy. (2016) (7)
- Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study. (1982) (6)
- Donor characteristics in allogeneic bone marrow transplantation. (1989) (6)
- Unrelated cord blood transplantation for correction of genetic immunodeficiencies. (2001) (6)
- Progress in Broadening the Uses of Marrow Transplantation: Donor Availability (1986) (6)
- Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells. (1985) (6)
- Expert Commentary: Practical Issues in Newborn Screening for Severe Combined Immune Deficiency (SCID) (2012) (6)
- Surgery of the immunodeficient child. (1985) (5)
- EBV Related B Cell Lymphoproliferative Disease after T Depleted Mismatched Bone Marrow Transplantation (1987) (5)
- Comparison of the outcome of unrelated bone marrow (Bm) Or cord blood (Cb) Transplant in children with acute leukemia (Al) (2000) (5)
- Allogeneic and Autologous Marrow Transplantation: Ex vivo Purging with Monoclonal Antibody or Immunotoxins to Remove Leukemic Cells or to Prevent Graft Versus Host Disease (1986) (5)
- Conjugated hyperbilirubinemia and renal function in bone marrow transplant recipients. (1988) (5)
- Healing hemophagocytosis. Discussion (2005) (5)
- Reduced Intensity Conditioning Is Safe and Effective for Transplantation of Patients with Shwachman Diamond Syndrome. (2007) (5)
- Pulmonary Hypertension (PH) in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TMA) (2012) (5)
- Prevention of graft rejection in allogeneic bone marrow transplantation: I. Preclinical studies with antithymocyte globulins. (1989) (5)
- Bone marrow transplantation in pediatrics. (1983) (4)
- Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients (2013) (4)
- Healing hemophagocytosis. (2005) (4)
- Donor and host influences in bone marrow transplantation for immunodeficiency disease and leukemia. (1993) (4)
- Cmx001 as Therapy for Severe Adenovirus Infections in Immunocompromised Pediatric Patients: Single Experience in 5 Patients (2012) (4)
- 410 The biology of Hemophagocytic Lymphohistiocytosis (1997) (4)
- Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation. (1992) (4)
- Advances in the Understanding of EBV Associated Lymphoproliferative Disorders (1991) (4)
- Somatic Gene Therapy for X-Linked Severe Combined Immunodeficiency Using a Self-Inactivating Modified Gammaretroviral Vector Results in An Improved Preclinical Safety Profile and Early Clinical Efficacy in a Human Patient (2011) (4)
- X-Linked Hyper IgM Syndrome (2013) (3)
- Prevalence of Viral Infections in Children Undergoing First Allogenic Hematopoietic Stem Cell Transplantation: Two Year Single Center Experience (2012) (3)
- Unrelated Donor Hematopoietic Cell Transplant (HCT) for Hemophagocytic Lymphohistiocytosis (HLH). (2006) (3)
- Tumors in Patients with Naturally Occurring Immunodeficiency Disorders: Report from the Immunodeficiency Cancer Registry (1985) (3)
- Cytogenetic studies in Wiskott-Aldrich syndrome: identification of a case with a 6p chromosome abnormality. (1986) (3)
- Peri-Transplant Alemtuzumab Levels IMPACT ACUTE Gvhd, MIXED Chimerism, and Lymphocyte Recovery Following Reduced Intensity Conditioning with Alemtuzumab, Fludarabine, and Melphalan (2016) (3)
- Comparison of enzymatic activity with evidence of engraftment in patients with inborn errors of metabolism receiving allogeneic marrow transplantation. (1986) (3)
- Adolescents and Young Adults With Hemophagocytic Lymphohistiocytosis Who Undergo Allogeneic Hematopoietic Cell Transplantation Are At Increased Risk Of Mortality Compared To Younger Patients (2013) (3)
- Successful Therapy for EBV Associated B Cell Lymphoproliferative Disorders in Immunodeficiency Using Alpha Interferon and Intravenous Immunoglobulin (1989) (3)
- Lymphoma and the immunocompromised host. (1979) (3)
- 496 DESCRIPTIVE EPIDEMIOLOGY OF MALIGNANCY IN ATAXIA-TELANGIECTASIA (A-T): AN IMMUNODEFICIENCY-CANCER REGISTRY (ICR) REPORT (1981) (2)
- Atypical clinical presentation of primary hemophagocytic lymphohistiocytosis with a novel perforin1 gene mutation (2013) (2)
- Immunodeficiency-disease-associated atypical chronic hepatitis: a clinicopathologic study. (1983) (2)
- Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders (2015) (2)
- Familial autoimmune disorders: emphasis on the polyglandular failure syndrome. (1985) (2)
- 806 IMMUNODEFICIENCY (ID) AS A SUSCEPTIBILITY FACTOR FOR MALIGNANCY IN ATAXIA-TELANGIECTASIA (A-T): REPORT FROM THE IMMUNODEFICIENCY-CANCER REGISTRY (ICR) (1981) (2)
- Hemophagocytic Lymphohistiocytosis Syndromes (2014) (2)
- Immune Reconstitution and Preliminary Safety Analysis Of 9 Patients Treated With Somatic Gene Therapy For X-Linked Severe Combined Immunodeficiency (SCID-X1) With a Self-Inactivating Gammaretroviral Vector (2013) (2)
- Chapter 52 – Histiocytic Disorders (2018) (2)
- Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease (2013) (2)
- Chronic Graft versus Host Disease: Interdisciplinary Management: Diagnosis and Staging (2009) (2)
- Outcomes With High Dose Chemotherapy And Autologous Stem Cell Transplantation (ASCT) In Comparison To Conventional Chemotherapy In Pediatric Patients With High Risk Ewing's Family Tumors (2010) (2)
- X-linked lymphoproliferative syndrome: an X-cellent question. (2006) (2)
- Primary Immunodeficiencies : Genetic Risk Factors for Lymphoma 1 (2006) (2)
- Erratum: Enteral metronidazole for the prevention of graf-versus-host disease in pediatric marrow transplant recipients: Results of a pilot study (Bone Marrow Transplantation (2004) vol. 33 (1235-1239) 10.1038/sj.bmt.1704474) (2005) (1)
- Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America (2014) (1)
- Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience (2013) (1)
- Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes (2013) (1)
- Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation (2015) (1)
- Lung involvement in the primary immunodeficiency syndromes (1992) (1)
- Transplant Associated-Thrombotic Microangiopathy (TA-TMA) In Pediatric Neuroblastoma (NB) Patients Undergoing Autologous Stem Cell Transplantation (ASCT): A Case-Control Study Identifying Early Clinical Markers Of Disease (2010) (1)
- Hematopoietic Cell Transplant for Patients With NEMO Defect: A Single Center Experience (2013) (1)
- Erratum to "Bortezomib for Refractory Autoimmunity in Pediatrics" [Biol Blood Marrow Transplant 2014;20(10):1654-1659]. (2016) (1)
- Gene therapy targets XLP. (2013) (1)
- Newborn Screening for Severe Combined Immunodeficiency (SCID) in Ohio: Using Algorithms to Standardize Follow-up Limits the Number of False Positive Results (2015) (1)
- Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants (2014) (1)
- Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87% (2015) (1)
- Non dermatomal rash and pancytopenia in a 5 year old child. (2014) (1)
- Emerging Targets for Hematopoietic Cell Transplantation (HCT): Genetic Disorders of Hematopoiesis and Immunity (2007) (1)
- Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics (2013) (1)
- Hemophagocytic Lymphohistiocytosis: Update of Biology and Treatment Options (2012) (0)
- Table 2. [Selected CD40LG Pathogenic Variants]. (2013) (0)
- Changes in Health-Related Quality of Life in Patients with Primary Immunodeficiency Disorder (PIDD) Between Time of Diagnosis and 12 Months after Initiation of Immunoglobulin (Ig) Therapy (2015) (0)
- Table 4. [Selected UNC13D Pathogenic Allelic Variants]. (2013) (0)
- Table 1. [Molecular Genetic Testing Used in X-Linked Hyper IgM Syndrome]. (2013) (0)
- High Dose Methylprednisolone for Veno-Occlusive Disease of the Liver in Pediatric Bone Marrow Transplant Recipients (2012) (0)
- CMX001 in the Peri-Engraftment Period Does Not Impair Neutrophil Recovery in Pediatric Allogeneic Hematopoietic Stem Cell Recipients (2012) (0)
- Controversies in Transplantation (2012) (0)
- Bortezomib Is a Successful Therapeutic Agent for Refractory Autoimmune Cytopenias in Children: A Single Center Experience (2014) (0)
- A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute GVHD in Patients with HLH and XLP Undergoing Allogeneic HCT (2013) (0)
- The Timing of Alemtuzumab Significantly Impacts Mixed Chimerism and Acute Graft Versus Host Disease (2011) (0)
- Lymphoid progenitor cells in severe combined immunodeficiency (2004) (0)
- Sa.49. Anti-IL-5 Therapy (Mepolizumab) for Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood and Esophageal Eosinophilia (2006) (0)
- Characterization of Cell Types and EBV Gene Expression in Lymphoproliferative Diseases (LPD) of Patients Receiving Bone Marrow Transplants (BMT) after T-Cell Depletion (1989) (0)
- Blood and Not Urine BK Viral Load Predicts Outcome in Children With Hemorrhagic Cystitis and Viremia After Stem Cell Transplantation (2011) (0)
- Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI) (2015) (0)
- Lymphopenia in Patients with Hemophagocytic Lymphohistiocytosis: Are B Cells Suppressed in These Patients? (2014) (0)
- High-Dose Weekly Ambisome Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (2011) (0)
- Marrow Transplant Registry and the National Marrow Donor Program Wiskott-Aldrich syndrome: collaborative study of the International Bone Impact of donor type on outcome of bone marrow transplantation for (2012) (0)
- Current Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients With SAP Deficiency and XIAP Deficiency (2011) (0)
- Alterations in Kv1.3 channels in tumor infiltrated lymphocytes of patients with head and neck tumors. (TUM2P.913) (2014) (0)
- Patients with Early Initiation of DLI for Mixed Donor Chimerism Were More Likely to Have Improvement in Donor Chimerism (2012) (0)
- T CELL DEPLETION WITH ANTI‐CD5 IMMUNOTOXIN IN HISTOCOMPATIBLE BONE MARROW TRANSPLANTATION: THE CORRELATION BETWEEN RESIDUAL CD5 NEGATIVE T CELLS AND SUBSEQUENT GRAPT‐VERSUS-HOST DISEASE (1990) (0)
- Interstitial Lung Disease In Patients With Underlying X-linked Lymphoproliferative Disease Resolves With Allogeneic Hematopoietic Cell Transplantation (2010) (0)
- The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies (2013) (0)
- Thrombotic Microangiopathy: A Major Complication of Bone Marrow Transplantation (2015) (0)
- Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion. (1985) (0)
- Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) (2013) (0)
- kinase Lck complex lymphocytes is mediated by the disc large 1-tyrosine 1.3 channels by protein kinase A I in T V Modulation of K (2016) (0)
- ALLOGENEIC BONE MARROW TRANSPLANTATION WITH RELATED DONORS OTHER THAN HLA MLC‐MATCHED SIBLINGS, AND THE USE OF ANTITHYMOCYTE GLOBULIN, PREDNISONE, AND METHOTREXATE FOR PROPHYSAXIS OF GRAFT‐VERSUS‐HOST DISEASE (1985) (0)
- Subcutaneous Administration Of Alemtuzumab (CAMPATH-1H) Is Well Tolerated And Effective (2009) (0)
- Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome (2013) (0)
- Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report (2006) (0)
- 412 Busulfan (BU) pharmacokinetics correlate with toxicity in children following stem cell transplant (SCT) (1999) (0)
- Table 2. [Summary of Molecular Genetic Testing Used in Familial Hemophagocytic Lymphohistiocytosis]. (2013) (0)
- Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study (2015) (0)
- B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report (2005) (0)
- Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment (2016) (0)
- Alemtuzumab for Steroid Refractory Acute Graft Versus Host Disease in Pediatric Patients: A Retrospective Review of 12 Patients Reveals a Response Rate of 83% (2012) (0)
- Disruption of membrane trafficking underlies the reduction in Kv1.3 channel surface expression in T lymphocytes during hypoxia (2011) (0)
- PREVENTION OF GRAFT REJECTION IN ALLOGENEIC BONE MARROW TRANSPLANTATION: II. PRECLINICAL STUDIES WITH THREE RADIATION PROTOCOLS (1990) (0)
- Symposium on Immunodeficiency and Cancer (1987) (0)
- Pharmacokinetics of high-dose weekly Ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patients (2005) (0)
- IDF Medical Advisory Committee Resolution on Product Choice for Immunoglobulin Replacement Therapy (2011) (0)
- F.76. NKT Cell Populations are Not Decreased in the Majority of Patients with XIAP Deficiency (2008) (0)
- children with active hemophagocytic lymphohistiocytosis Gene expression profiling of peripheral blood mononuclear cells from (2013) (0)
- Expert Commentary: Practical Issues in Newborn Screening for Severe Combined Immune Deficiency (SCID) (2011) (0)
- Viral Infections in Children Undergoing Autologous Hematopoietic Stem Cell Transplantation (2012) (0)
- Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience (2013) (0)
- Alemtuzumab Is an Effective Salvage Agent for Refractory Hemophagocytic Lymphohistiocytosis (2012) (0)
- ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report (2006) (0)
- Adolescent presentation of x-linked lymphoproliferative disease. (2008) (0)
- The path to cure of primary immunodeficiencies: Current and future approaches to gene therapy with stem cell transplantation (1994) (0)
- IDF MEDICAL ADVISORY COMMITTEE (2013) (0)
- Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant (2015) (0)
- Rapid Detection of SAP Deficiency in Cytotoxic Lymphocytes from Patients with X-Linked Lymphoproliferative Disease and Their Family Members. (2004) (0)
- Perforin Polymorphism A91V and Susceptibility to Childhood Acute Lymphoblastic Leukemia (ALL). (2005) (0)
- New M alignant D iseases A fter A llogeneic M arrow Transplantation f or C hildhood A cute L eukemia (2000) (0)
- Table 3. [Selected PRF1 Allelic Variants]. (2013) (0)
- Table 1. [Locus Names, Genes, and Pathogenic...]. (2013) (0)
- Norovirus Gastroenteritis – An Emerging Pathogen in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients (2012) (0)
- Use of DNA polymorphic markers to determine the chimeric status of matched and mismatched patients (pts) following bone marrow transplantation (BMT) (1984) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation For Immune Dysregulation, Polyendocrinopathy, X-Linked (IPEX) Syndrome Resolves Enteropathy and Autoimmunity: A Single Institution Experience (2014) (0)
- Alemtuzumab Pharmakokinetics (PK) in Pediatric Patients Undergoing Allogeneic Hematopoietic CELL Transplantation (HCT) (2016) (0)
- OR.6. Loss of SAP Expression in XLP Patient T Cells Impairs TCR-induced Apoptosis Independent of EBV Infection (2008) (0)
- Reduced intensity Conditioning for Second Hematopoietic Cell Transplantation in Pediatric Patients With Relapsed Acute Myeloid Leukemia Following Allogeneic Transplantation (2011) (0)
- Prenatal Origin of Monosomy 7 in Very Young Children. (2012) (0)
- Correction of primary immunodeficiencies with bone marrow transplantation from unrelated donors (1999) (0)
- Discussion on Childhood Malignancies, Lymphomas and Leukemias (1985) (0)
- with adult-onset familial hemophagocytic lymphohistiocytosis Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated (2012) (0)
- Systemic Activation of Macrophages by Interferon-gamma Rapidly Induces Severe Anemia and Hemophagocytosis (2010) (0)
- BONE MARROW (BM) LYMPHOID PROGENITOR CELLS IN SEVERE COMBINED IMMUNODEFICIENCY (SCID) (1984) (0)
- Sa.60. Anti-IL-5 Therapy (Mepolizumab) for Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood and Esophageal Eosinophilia (2006) (0)
- Possible Role in T Cell Proliferation Kv1.3 Channels in T Lymphocytes: A Hypoxia Regulates Expression and Activity of (2002) (0)
- The use of monoclonal antibodies in human bone marrow transplantation. (1984) (0)
- Reducing Outpatient BMT Clinic Visit Times (2011) (0)
- 99 Severe combined immune deficiency (SCID) characterized by CD8+ lymphocyte deficiency and defective lymphocyte activation in two mennonite families (1991) (0)
- Prospective Evaluation for Clinical Indicators of Pediatric Hematopoietic Stem Cell Transplant (SCT)-Associated Thrombotic Microangiopathy (TMA) (2012) (0)
- Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene (2014) (0)
- Anti-IL-5 Therapy (Mepolizumab) in Hypereosinophilic Syndromes and Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood Eosinophilia (2006) (0)
- The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901 (2013) (0)
- Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute GVHD and Mixed Chimerism (2015) (0)
- reduced intensity conditioning Successful bone marrow transplantation for IPEX syndrome following (2013) (0)
- F.51. Altered Dynamics of Kv1.3 Channel Compartmentalization in the Immunological Synapse in Systemic Lupus Erythematosus (2006) (0)
- CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease (2013) (0)
- Successful Outcomes Following Matched Unrealted Donor BMT for Wiskott Aldrich Syndrome (2010) (0)
- BActivation Mediated by Fas versus Granzyme Reveals Distinct Patterns of Caspase Real-Time Detection of CTL Function (2014) (0)
- Table 5. [Selected STX11 Allelic Variants]. (2013) (0)
- Table 6. [Selected STXBP2 Allelic Variants]. (2013) (0)
- Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. (1992) (0)
- 2 CD 4 + Invariant Natural Killer T Cells Protect from Acute Graft-Versus-Host Disease Lethality through a Dramatic Expansion of Donor-Derived CD 4 + FoxP 3 + Regulatory T Cells (2014) (0)
- BK Viremia Is Associated with Cyclophosphamide Use and Graft Versus Host Disease (GVHD) in Pediatric Hematopoietic Stem Cell Transplantation (SCT) (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alexandra H. Filipovich?
Alexandra H. Filipovich is affiliated with the following schools:
